Search

everythinglearnresearchcommunity

for

Search:↓

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The study found that sweat glands normally suppress immune responses, but this is disrupted in certain skin diseases, possibly contributing to their development.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

IL-1 signaling is crucial for hair follicle stem cell growth and wound healing.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

A young man was unexpectedly diagnosed with basal cell carcinoma after a scalp examination and confocal microscopy.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Fucoidan reduces bone cell formation by affecting T-cell activity.

A sugar glider had a rare skin cancer that worsened despite treatment, highlighting the need for thorough checks in exotic pets.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.

Blocking interferon-gamma helps prevent and treat hair loss in Alopecia Areata.

Eating grape powder may reduce the severity of skin allergy symptoms.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Human body's immune cells are more common in the layer of fat just beneath the skin than in deeper fat layers.